Lukas Jeker։ Making Genomic Medicine Affordable for More Patients
Lukas Jeker, Assistant Professor Experimental Transplantation Immunology and Nephrology at University Hospital Basel, shared a post on LinkedIn about a recent article by Fyodor Urnov and Sadik Kassim, published in Nature։
”Very thoughtful words from Fyodor Urnov and Sadik Kassim.
Time and costs to perform safety and efficacy testing are key obstacles that prevent more genome-editing therapies to benefit patients.
Fyodor and Sadik outline 4 key aspects that need to change to move faster, cut costs and scale.
I hope they are correct that costs can be cut dramatically and I hope successful deployment will convince other regulators to adopt similar regulatory frameworks.
Some of the article is US-centric but similar principles can be applied to other legislations.
Some principles will be universal (mainly scientific), others will need local adaptation, and maybe someone can further improve the approach?
Looking forward to what’s to come.
Thanks Fyodor and Sadik (and the many others who are pioneering such treatments) for your energy to bring change.
The last paragraph is particularly strong!
Read it (including the dollar COI disclosure).
I hope there will be a time when we look back and say: yes, there was a time when genomic medicine was unaffordable for most people.
Personalized CRISPR therapies could soon reach thousands – here’s how.”
Title: Personalized CRISPR therapies could soon reach thousands — here’s how
Authors: Fyodor D. Urnov, Sadik H. Kassim

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH